Use of exercise doppler echocardiography to evaluate cardiac drugs: Effects of propranolol and verapamil on aortic blood flow velocity and acceleration  by Harrison, Michael R et al.
oppler Echocardiography to Evaluate Cardiac Drugs: 
f Propranolol and Verapamil on Am-tic Blood Flow Velocity 
and Acceleration 
WCHAEL R. HARRISON. MD, MIKEL D. SMITH, MD, FACC, STEVEN E. NISSEN, MD, FACC, 
PAUL A. GRAYBURN, MD. ANTHONY N. DEMARIA, MD, FACC 
LEr*pro”. Kmtricl~~ 
This sLu*y e”duated the ability of exerck Doppler Klw. 
cardiography to identify bemodynamic chhsnges due to 
cardiac medicalion. Twenty young beallhy vohmtnrs 
0mm age 30 yenrs) underwent antinoous wine Doppler 
examinstion from the supms,emal notch at rest, during 
each suee ofn standard exercise q rotwo, and b”med,sl~ 
aner e&&e. On comp,&” If the cmtml test, each 
rubjec, received either 60 b 80 mg of pmpraaolol or 120 
mg al vernpamil orally, and the sane erercb prot~ro, was 
repeated akr 90 min. 
proprsndd an awe,emtinn was even greater, wilh blunting 
of baseline (11.4 t 1 VPAUS 15.4 * 5 m!s p+r s; p < O.w(15) 
and ewtional(33.4 t 10 versus 56.3 * I5 Lois per s; p < 
O.wO,) ace&ration. The Row velority lntcgrnl during 
e%erciS wps greater anrr prqIranolol 04.1 * 3.1 vers”s 
10.1 d 3.2 cm; 9 < O.ooO5, than during the cWlml test. 
Vera~~nrnil f&d to Muence any Dowkr-measured index . . . 
oi am?& blood Bow. 
1, is concbakd Ihs(: 1) wo9fm1olol exerts a pmiwnd 
bemodynarnic effect m meawed by lbwdar wlwcardbb 
rapby a, resI and during exercise, 2) dmpile L n+ga,,ve 
inotropic properties, prepranok4 rwdts in an increased 
stroke volume during cxrrck nppuently beaus of in. 
crud pnlor@3) verapsmil, in the dosaw studied, dms 
not titer the Doppler-mewred exemise resp” in young 
ballby subjecb, and 4) Doppler e&cardiogrPpby is a 
useful techrdqne ior evaluating the bmcdyrcamic eUecrcto of 
medication on aorde blood Row at rest and during aerciw. 
Duriiag the ran,ro, Lest, “nl”fS for modal “ehci,y, 
accelciadcm and Row v&&y ink& all increased signif- 
icantly irom baseline (p < O.O@OZ ior each). What exercist 
was re,x+d tier propranolol sdmbdstmiion, values ior 
a,, Domdermeas”remPnl were sienificantlr &red. MC&, . I 
r~locily 81 baseline was sigmificantly Sewer alter proprano. 
,a, when compared with cmdmlfO.53 t 0.11 versus 0.63 t 
0.17 m/s; p < 0.000,). Similarly. modal veloclfyat maxbnnl 
exercise was si@iczmt,y lower after propranolol (1.11 + 
0.2 venw 1.25 t “2, rids: p C O.OOOll. The e&t al 
(, Am co,1 CMuol I9aa;Il:Iom-9) 
Doppler echocardiognphy is a relatively new technique that 
enables accurate noninvasive assessroenl of aortic blood 
flow (II By vinue of 11s abibt? 10 reliably measure blood 
Row vc,ocity and acceler~ !ion in the ascending aorta, Dop- 
pler c:hocardiography rvovides a convenient means by 
which Io evaluate left vet :ticdar function 0-O. Because it 
is a noninvasive technique. it can readily be used to pelform 
serial evaluation of individual subjects. lmporiaidly, DOT- 
pier methods we well suited to evaluate left ventricular 
performance during exercise. 
The abilitv ,(I assess both rest and exercise left ventricu- 
lar pe!fwma& afforded by lroppler echocardiography pro- 
vides an excellent opportunity lo study the hemodynamic 
effects of cardiac drugs. This is of particular importance 
because few data exist regarding the inauense of cardiovas- 
cular medications on cardiocircuiatory function during vig_ 
moos exertion. Wilh this in mind, we studied the effects of 
propranolol and verapamil (two antianginal drugs with neg_ 
alive inotropic properties that exert their effects by ddlkrent 
mechanisms) on Dopplerderived measures of left ventricu- 
lar performance at rcs, and during exercise. These srudics 
not only provide insighr into the circulatory aclions of these 
drugs, hu, 81%~ they delmea,ed Ihc altcr.t,iom in Doppler 
mea~uremen,, a, rot that could he Induced by rhesc a%emi. 
Methods 
Study patients. The sludv wow comntcd of !I) voluri- 
teen (8womcn and 14 men, iirho mean age of 311 ye,ur 
(range 22 to 421. Each subject wils free of any x~ie ,,r 
chronic illness as detcrmincd by Wary. pby$cal eurnin.l 
tion. electrocardiowam IECGI. two-dimenwmai echoc.~~. 
diagram and exe&e electrocardiogrnm Uhougb all wt,- 
jects were in general good health. they v,ned in 
cardiovascular conditioning from iedcatary to well ,wncd. 
No subject WE rccciving medication at the lime of the study. 
Informed consent was obtained before the hwt of the \tudu 
protacol. 
Exercise testing. Each subject underwent control tread- 
mill exercise testing in the postabsorptive ate usmg the 
Bruce orotocol (5). Exercise was continued until at least 85% 
ofthe &e-predicted maximal heart rate was achieved. Once 
the heart rate criterion was fulfilled, the treadmill wit\ 
slopped and the final phase of the Doppler exarmnauon was 
immediately hegun. No “warmdown” period was ubed. 
Blood pressure was recorded by culTfrphygmomanometer at 
baseline and I m;n after exerctse. while corsinuous ECG 
monitoring was maintained with a multdcad recording *yr- 
tern throughout the exercise test and during the first 3 min of 
sound examination was performed with subjects in Iha 
standing position ~1 baseline, during the final 90 \ of each 
exercis; &Se and immediately aft& exercise. Recording, 
were made from the suprastemal notch using a nonimaging 
franeducerangulated to record the maximal Row signal in Ihe 
ascending aorta as defined by the audio output and light- 
emitting diode. At least IO beats were recorded during each 
phase of the exercise protocol. The instrument used in the 
sludy (Excrdop, A.H. Robins) is capable of measuring 
modal velocity (the velocity at which Ihe grcawst numhcr of 
red blood cells are tmvelingl. Thia cooliouou~ wave Doppler 
transmitter and rccciver operate at 3.0 MHc. The received 
Doppler-shifted flow velocity signal i\ sampled every 5 ros. 
and the greatest modal velocity for each systole is printed 
out a~ peak ma&d velocity for that heartbeat. Peak acceler- 
ation and Row vclocily integral are derived internally at a 
high sample rate of 200 Hz. The Swab% increase m peak 
ioit8nxmeou~ velocity from one s~rlple 10 tbc nw is the 
peak acceletadon for that beat. 
llvflyi (I I rhc l”rlr”menl accuralely g,icnrge, YII,I,C\ fur 
modal \c,oclly. accelcriition sod flow wIncity ~nrepnl nb- 
taimd durmg each level of exenion. and prowdcr a prm!zd 
dW!Il %ldWl of these value5 wg. IL Specira, trnc@ of 
the ~~eIoc11v profile are nor prowled hy thi5 ioctrumeot: 
however. prewnuc \tadtes (61 ,o our lehoratory comparing 
Ihv d~wcc wlh another machine ,lrcr) dcmons,;awd that 
the vclocQ dara wue rimilar. Al!hough the velocity infor- 
matmn provided by this machme IS derived from mcawrc- 
rncul of rnud.d vrlocily and i\. thereforc. wmewhot lower 
than vmuitaneow rezdiops of maximal Y~I~~IIY. the rewlt\ 
are noncthelea\ very simdar and parallel thrnuphout thr 
couric oi on cxerclse test (61. The valuec reponed in ihn 
study are deriwd fmm the arithmeric .,vengc provided by 
,he d,g,lal prinrour of the ~ns,rw,,cn,. 
Study protocol. On completion of the iniliel control exer- 
we te\t. each rubjecr received either 60 mg twomen) or X0 
m* Imen) of propmnolol or I20 mg of verapamil orally. No 
other wh%ance (orher lhvn water) *a\ taken unlil after 
complcuon of ihe second exercne tea Nmery m,nu,e~ after 
admm,\rra,ion of medication. the cxerciw protocol wx\ 
repealed. wth each subject required tc continue the exercise 
protocol for exactly the same duration a$ accomplished io 
the be\eline ie\t. On another “sty. under similar conditmn\ 
and uwg ttw same 20 ruhjccts. Ihe exercise and Doppler 
\tudie\ Iincluding a control test, were repeated usmp the 
alternate phammceu,,ca, age”,. Serum !eve,< of propranolo, 
were not ohtamed. Howcvcr. on the haw of m~i,i,, rcw,~\. 
blood \amp,c~ were drawn from eighl wbjecl\ )a\( hefore 
the final exercise test for detcrminaion of the plasma verii- 
parnil concentration. 
Statistical analysis. Student‘s f tcbt fur paired data WI\ 
performed between I) the results for the two control tests. 
and 2: each control test and it\ corresponding drug. 
;zRuenced ~1s. DitTerencc, wcrc analyrcd for hcan rate. 
exercise duration. modal velocity. acceleration and flow 
velocdy integr.d. A p value of Gl.05 was considered signif- 
icant. In addmoo to analyGs of rhe abwlute chaogc bore 
baseline tu peek exertion. Doppler vanahles wcrc al%” 
analyrcd for the percen, change from baseline. 
Results 
Control rerolls. Exercise and Doppler protocols were 
auccwfully performed I” all 20 rubjccth during the wo 
comrol lest\. Rest and exercise hean rate. systolic and 
dwtolic blood prcssurs. peak modal velocny. peak ecceler- 
alion and fluw velocity integral were a,, similar for both 
control tat\. indicating a r&factory degree of reproduc- 
ibility with this method. Exerube duration was slighlly 
Ikmrer durinn the wcond control test (1 I .9 L 1.4 ver\u 12.6 
z I.7 mm: p < O.OSI. dcspilc rhe absence of change in 
phywa, act \,,y be,ween ,hP two lc<l,. In the conlrol 
pcwd. pwk rmoda, velocity increased from 0.6: + 0.17 m/s 
1 baseline tu I.25 + 0.21 mb immediawly after exercise (p 
< 0.0002~. Similarly, peak acceleration (15.4 t 5 loS6.3 + IS 
m/s per 5) and Row velocity integral (7.3 + 2.4 to 10.1 + 3.2 
cm) increased significantly during exercise 1p < O.OiM2 for 
each) (Fig. 2). Flow velocily and acceleration increased 
progressively wdh inwe& levels of exertion. with the 
greatest change between stages occurring from rest 10 stage 
I. The flow velocity mregral awn underwent Ihe greatal 
increase between rest and alage I, but thereafter was un- 
changed until the end of the test. 
E&cl of propranolol. During the propranolol test. 1s of 
the 20 subjects successfully completed the exercise profo~ol. 
Because of exhaustion. two bubjecfs could not achieve the 
total exercise duration of their control tests lone by 60 s and 
the other by 30 I). The results of the study were unchanged 
after these two subjects were elirxinated, and the data from 
both subjects are included since they successfully completed 
the verdpamil protocol. 
ffeo,; n,,e ;, ,ts, (64.7 + 9.2 venus 77.4 t 14.8 beats 
Imint and heart rate z&maximal exercise 1130.8 + 11.5 vcrws 
170.1 2 10.2 beasimin) were significantly depressed during 
the propranolol rludy relative IO control (p < O.wOZ for 
each). The increase in heart rate during exercise was signif- 
icaslly blunled during the prapranolal lest compared with 
control (66 c 12.9 versus 92.7 * 12.6 beatslmin: p < O.oWI) 
owing 10 the marked depression of exercise heart rate and 
the modest depressmn of the heart rate al rest. Systolic 
blood prerrure at baseline (IO4 + 10 versus i 16 f 14 mm “g, 
and at L mm afterexcrcisc (136 i 15 versus 161 f 19 mm Hg) 
was also depressed after propranolol relative to control tp < 
O.oWI for each). Diastolic blood pressure was not ,ignifi- 
candy allered by pr-pranolol al baseline or al I mm after 
exercise. 
PM~ modnl wbril~~ m rr.u was rieniticantlv reduced bv 
p.opranolol relative to comrol (0.53 > 0.11 versus 0.63 -c 
0.17 mix p < 0 ooOl1. Peak m&l velocity 10 maxtmal 
exercise was also significanlly lowr afier adminisiralion of 
propranulol (I. I I 2 0.2 versus 1.25 t 0.21 m/s: p < O.iMOl). 
Although peak modal velocity values at rest and during 
exertion were depressed by pmpranolol. both wcrc de. 
pressed lo a similar extent. Thus, the increase in Row 
velocity during exercise expressed as a” increwe from 
baseline was wt altered tq propranalul when compared wvith 
control (Fig. 3). 
Peuk acceleration 01 WI was significantly reduced by 
propranolol relatwe to c(miroI (I 1.4 t 2 YFIS”L 15.4 r 5 “?I* 
per s; p C O.OGW. Peak acceleration ill maximal cxuIion 
was also significantly reduced after propmnolol (33.4 ? IO 
versus 56.3 +_ 15 mis per E; p < O.ooOl). In wntra~~ IO Ilow 
velocity. the blunting of peak acceleration by ~ro~ra”oloI 
WLS mwe marked during exercise. Thus. Ihe mcreax m 
acceleration during exercise expressed as an mcrcax from 
baseline was significantly blunted after adminirlration uf Ihis 
beta-sdrenergic blocker (21.9 ? IU versus 40.8 i I2 m/r per 
E; p < O.M)S) (Fig. 4). 
Flow velocity inrugrd UI rm IYW , (I! aherd hy pwpm~z- 
ulul: at maximal exercise. however. it was aienificandv 
augmented afler adminzstration of propranolol (i4. I z 3.i 
versus IO.1 + 3.2 CXI: PC 0.0001). Becsuse the Row velocw 
inlegrai was altered b; propranolol only during exenio”. 11; 
increase during exerwe expressed as a” increase from 
baseline was sigmficantly greater after admmi~betio” ot 
propranolol than during control (6.8 2 2.7 vcrws 2 8 * 2.8 
cm; p < O.W5) (“I& 5). 
Effect of verapamil. All 20 subject\ reccwmg verapamil 
achieved lhc same cxerci% duratiun achieved in the comrul 
test and succc~fully completed the exercise promcol. Hean 
rate at baseline was unchanged fram comrul. but heen rate 
at maximal excrcisc was slightly dlrnlnirhcd llffl.1 z I3 I 
versus 167.4 + 9.7 beatslmin: p < 0.051. This reudled in a 
small but slalistically rigndicarn blunting of the exe&e 
,nduccd ~ncrrare I” he”” raw durmg the vcrapam,i ,CI~ 181 8 
2 17.6 ver\u, xx.5 i; 13.1 bsatamn: p < “.“S, syilulic 
blood pre\wrc nt bacline wa\ \iightly lower &r verapam 
Cl I? + 8 YCIWS I I6 z 8 mm Hg: p < 0.05). but systolic blued 
preuure I min after ewrcire ~a> unchanged from conlrol 
after vsrqx~mil. Diwohc blood picsaurc wd> slightly luwcr 
al rc~t after vcrqwrdl (76 2 8 verse 81 f 8 mm Hg: p / 
0.05). bu uils unchanpd relalwe IO control I mm after 
1 
t’ 
1 
levels at 90 mm ancr oral odministralion ranged from 84.4 to 
202.2 @ml (mean 129.4 3 34.5). The therapeutic range for 
verapnmil levels at which clinICill effects are sceo at the 
laboratory used in this btudy is SO to 150 ngIml. 
Discussion 
Doppicr ecbocardlography provides a convenient nanin. 
va’iive means ofcvalu&g left ventricularfunclion (14). By 
providing accumle mea~oremenfb ofaorlic blood flow veloc- 
ity and acceleralion al rest and during exercise. Doppler 
echocardmgraphy may furnish a means @I” evaluating the 
hemodynhmic consequencer of cardmc medic&ws in both 
state\. The re~ltr ofour study clearly demonstrate the value 
O? Dopplsr recordmgs in III!> application. and establish that 
a decrease in Doppler meawrements of left ndricular 
function occurs both al rep and after exercise after the 
administration of prop~annlol. but not venpamil. 
Response of blood flow velocity to cxerciSe in the eontrot 
state. A consistent pattern of res~onre of blood flow veloc- 
ity to cxerci% was ohrerved III young normal subjects in this 
aludy. In the control slotc, oortic flow velocity and atcccler- 
alion increased progrraaively during exercix. and thr great- 
es1 increiae occurred bcwcen rest and atape I, Thcrc 
tindow are cm agrsemcot with prcvioor ~rports (7.81. and 
subr&nt,ate that o prominent increase in left wotricular 
function 1s asrociated wlh even mild exercise. Specifically. 
Daley CI al 181 soled a mean maxima! velocity of0.75 m/r at 
rest and 1.39 m/r al pc!~k cxercisc. There voIue\ arc very 
similar toou~ rrwI11 using modal veloc~y to,63 and I.25 m/b. 
respcc!ivelyl. Fkw viiocoy mtegral mcawrementa also 
increased substanlially wilh mild enercirc during rlnce I, 
and thereafter tcndcd IO stay IweI until the end of the‘tcs!. 
The 39% increw in flow velocity integral during excrci<e in 
our control test< i< comparable with that reported by others 
l7.R!. 
tnfluence of propranolol. When patients were studied 
after receiving propranolol. Doppler flow measurements 
were altered both at rest and during exercise (Fig. 3 sod 4). 
Peak Row velocity at rest was significantly depressed by 
propranolol, as ws peak flow velocity at maximal exertion. 
Although peak Row velocity during both rest and maximal 
exercise periods was significantly diminished by this beta- 
blocker, a progressive and normal increase from baseline 
was maintained. Thus. rest and exercise Row velocilies were 
diminished to a similar extent. and the percent change from 
baseline duriq exercise remained the same. These data 
verified the findings of earlier work (9) employing epicardial 
markers. which demonstrated that the change in velocity of 
lead motion per time is reduced in the presence of beta- 
adrenergic blocking agents. The most profound CR-C! or 
aortic blood Row produced by propranotot was Ihe reduction 
in Doppler measurements of acceleration. Not only were 
acceleration values at rest and during exercise diminished. 
but the blunting of acceleration was greater during exercise 
than at rest. II most be emphasized that the exercise protocol 
and conditions were identical for both baseline and propran- 
olol te(ts. Indwd, the only difference between the two test: 
was the prc~ence of drug for the propranolol test. 
Aortic flow occciontion is 11” e.rpression of t/w force 
being applied 10 blood by rhe cowwiny myocordim (10). 
Previous work (4) has shown a strong correlation between 
aortic Row accewration and rest kfl ventricular ejection 
fraction by vcntriculography during cardiac cathcteriration. 
Not only is acceleration an accwate predictor of left veotri- 
colar function, but also it is insensitive to changer in preload 
(3). Indeed. evidence IS accruing to soppon the concept that 
flow acceleration is a useful index of myocardnal contractility 
(I I.IZ). The demonstration in the present study that flow 
acceleration is algnificantly reduced both at rest and during 
exercise after propranolol is thus indicative of a negative 
inotropic effect induced by this agent. 
(7,8./3,/4). Estimates of stroke vuiume, derived as the 
product of the Row velocity integral and the diameter of the 
proximal aorta, have been shown to increase during upright 
exercise (7.8). The mechanism for this increase in stroke 
volume with exercise remains uncertain. but it is thought to 
be a combination of increnced prrload lthe Frank-Starling 
mcchani%m) and *?h?xvi ronfractility (15). Despite the 
negative inotroplc action of propranolol. its administration 
not only WQS accompnnicd by an augmentation of the exer- 
cise flow velocity integral, but also resulted in a aignificimtly 
greeter increarc in the flow velocity integrel fwm hsaclinc 
,han occurred during Ihe conlrul test IY5 verw~ iY:i) lFrg 
5). These dara are indicativr of an augmrntal~on of \,rokc 
volume during exercise af,er propranolol. and arc conGlen, 
wi,h resuks of a previous rcpo” ,161 usmg invawe hemo- 
dynamic measuremen,s Presumably. an acceleramn in 
heart rafe was the major factor recponvhle for the incrca~c 
in cardiac output during the contiol ,a, Durmg the propran- 
olol lest. however, the heart rate recponsc ua\ dmlted. md 
an enlarged stroke volume conlribatcd ,o a grater cardsc 
output. 
Because propranolol blocks an increase in con,racrday. 
as evidenced by decreased acceleration. our data mduie 
that the Frank-Srarling mechanism. by ray of mcrea\cd 
venoos return. played the primary role I” mcreaGng irrokc 
volume during exercise after adrmmsrraon of rhi; ugen,. 
We found support for this contenbon by calculating m index 
of cardiac output from ,he product of heart raie and Row 
velocity integral. This product a, rest wa\ rigndicandy lower 
than control level after propranolol !p < 0.0051. At peak 
exercise, however, this product did not differ from control 
after propranolol. desptre the reduction 10 hean rate during 
the proprenolo, test. This implies ,hai cardiac output was 
reduced slightly at rest by propranolol. but. wi,h exercise. 
increased to the level seen during the control test, preun- 
ably as a result of augmented venous return. 
lotlaence ei vrrapamil. To evaluate the hemodynamx 
effects of another clash al antianginal medication. the exer. 
cise Doppler protocol wes repeated m the sane study 
subjects using verepemil. The results of this study demon- 
strated that wrapemil has no e6ect on meesuremen,s of Row 
velocity, acceleration or Row velocity integral. To ensure 
absorption of the drug. plasma samples were withdrawn 
from eight subjects immediately before the verapamd exer- 
cise test. Plasma verapamil sampler were well within Ihr 
range of levels a, which clinical efficacy i) xen. 
The resrrhs of rhe vernpsmil resr wcm umrperred. Clan- 
ical trials (17.18) have shown verapamil m be an effccrwc 
antianginal agent with signitican, negative inotropic proper- 
ties. Our data indica,e that a single dose of verapamil has 
little effect on left venbicular function. either a, rest or wdh 
exertion as determined by the variables measured. WC did 
not directly measure left vemricular prcload in this study. 
However, because the other dctcrminants of myocardia, 
oxygen demand do not appear to be influenced gready by 
verapamil. we interpret oar d&a to indicate that the antiangi- 
nal effects ofthis aqnt are due. in part. to mechantrms other 
than decreased myocardial oxygen demand. 
Ellect ofheart rate. The disparae effec,s of propranol~, 
end verapamil on velocity and accelera~on did no, appear 10 
be related to the greater blunring of exercise-mduccd lachy- 
cardia by propranolol. Linear regression analysis comparing 
th< change in hear, rate that occurred with exercise ailh 
either the change in veloci,y or the change I,: ucrclerat~u,i 
rcvealed a correlation cocffiuen, ,r) of < 0.50. Funhermore. 
o r&cm \,udy (IY) in Ihc dog model found !ha, pacing. 
mduccd dl,cm,ions m heart rate re\u,ted m e\\en,~ally no 
change in Doppler-dewed YB,UCI for peak flow vclocily and 
dccclcra,~on Those invertiwators al50 noted a vgmdcun, 
dccrrr\c in both rest flow vekxity and accelcraion a&x 
Jminirtratwn of propranolol. Similarly. Klinkc et al. (20) 
uwd a where,-upped Row ‘reloc,,~ probe ,o rtudv oa,,cn,s 
at res,. They showed that propranoiol cawed d &&xd 
decreae in aortx Row velocity and dcccleruion rha, per- 
Ned when negative chronotropx ekec!c were abohched by 
pilcmg. 
Limitations of the r!udy. Several lecbnical aspecrs of the 
Doppler methods empk>yed in Ihis study warrant emphasis. 
Excrcw Dopplerschocxdiographic rtudie~arrume that rhe 
cro~wcc,iuwal area of the proximal aoona remams on- 
changed from one level of exerci% 10 another. If ,hc 
awendmg aorta expands s&&m:ly as left ventncular 
funclion changes with exercice, ,he measured imcgratcd 
Row wlocaty would no, accurately r&c, the exerc,se- 
induced alteradon in smoke voiume. Although ,hc prox;imal 
awla 15 known 10 expand dunng cyctole (21,. I, ic o”c~-i 
whether sys,oIic expanston IS greater during cxercirc rcla- 
we 10 rer,. Because stroke volume doting exercise is geater 
than stroke volume at rest (22). it might be assumed that 
systolic expansion of the proximal aorta would also be 
greater durmg ercrcise. In contrast 10 lha, awmplion. some 
mveitigalors 1231 have observed Y slight decrease in am,‘: 
diameter durmg submaxmml exercise. Although the pa~~c~,y 
of lnformalion regarding the change m sonic cros+-Lcc,ion:d 
areadurmgerrrcise and the knwn loss ofaortic complianw 
with increasingage and some disease states may limit the uce 
of cwrcw Doppler echocardtosraphy in some respec,~. m 
oar a,udy we observed the iniluence of a pharmacologic 
intervention m young indiv,du;ls who undenven, identical 
levels of exercise on the sernf. day before and after drui: 
admmiatratian. I, is unlikely that changes large enough 1, 
a~gmficandy alter our findings could have occurred in aorlic 
cross-sect~omd area es a result of drug administration. As 
regards the examination itself. motion artifact can limit the 
Doppler examination. In this respec,. we found ,ha, ,,age 4 
wa3 ,he higher, level of excr,i,m during which the Doppler 
cnamiwtion could be performed reliably. 
B<carw a/l Doppler rmrdinpr we,e done iwith wh,em 
in (I .srmlaa pmirion, positional changes that could have 
altered Doppler-derived values were avoided 18). Finally. 
although rhe effects of rcspirarmn were no, a problem in the 
suhJecf\ in our study. rhese factors may limit the technique 
an patrenlr wth significant lung diceasc. Similarly, use of a 
continooo~ wave device that wab specifically designed for 
we with exercise avoided problem associated with mainlr- 
nance of a constant sample volume sile or ‘aliasing” a, high 
Row rate,. 
[ion of,hc drug, wa\ confirmrd hy heart rate reqxnrc and 
strum drug In&. we cannel dircounl the powhilily lhat 
mamtcnance doses nfpropmoolol and verapnmil might have 
led to dilicrcnt results. In addition. il i5 nol known with 
certainty if re\ponrcc xmdw 10 Ihow seen in tbw young 
normal sub~ecls would bc obicrvcd in older patienls with 
hear, direasr. 
Clinical implications. Although prcviow studies (7.24-271 
have cugpead thal exercise Dopplerechocardiography may 
bc useful in identifying patients wdh hemodynamically sig- 
mficanl coronary anery stenosis. Ihe potential influence of 
beta-blockers has often been ignored. Mehla el al. 127) 
apec,fica,,y made no a,,cmp, 10 account for the effects of 
beta-receptor blockade. because group mean values for flow 
velocity and accclcration were not significantly different 
between those who did or did not receive a bela-blocker in 
their study. No information WBE provided regarding drug 
doragc in their rh!dy. Other workers 17.26). using exercise 
Doppler echocardiography to Identify coronary arlery dis- 
case. also did ml consider the potential elfects of cardiac 
medicaliuns. Our results show a clear influence of bcta- 
adrcncrgic blockade on both sonic Row velocily and accel- 
eration. Future studies of left venlricular fun&n and exer- 
cwinduccd myocardial ischemia usinq Doppler-derived 
blood flow me.lsurements mum! accoun, for Ihe effects of 
bela-blockade and possibly other cardiovascular medica- 
tions. 
77~ rcwrrd w~l;or rlinicol rmplh orion 0J 011rdl~~Iy rc&trd 
I0 rhr heniodwamk e&e \ qf mrintr~if~ol ugems. In this 
regard. our data dwmnstratc thal propranolol and vcrapamil 
exerl different ciTects 011 left vcnlrictdar function as assessed 
by Doppler Row recordings. Verapamil had no effecl on Row 
velocily or acceleration. implying thal the primary anti- 
lschemic a&n of thtr agent involves mechanisms alher 
than reduced myocardial oxygen demand. As recently 
poimcd wl by Fnrhman and Charlap (28). the mechanism of 
antianginal efficacy for calcium channel blockers is no’ 
totally clear. Conversely, proprannlol was accompanied 
by a reduction in Row acceleration and an augmentation 
of Integraled Row velocity. implying decreased inotropy 
and incrcarcd slroke volume ioduccd by enhanced p;e- 
load. 
Conclusions. The rcwbs oi this study demonbrmle that 
Doppler whocardiography not only enable, noninvaive 
evalualm of left ventricular function. but also provides 
insighl into the mechanisms and hemodynamic effects of 
lhcrapculic agen& both at ml and K .ih exercise. In light of 
the:: Sing,. ne believe thal exeicix Doppler Row vcIoc- 
ily recordings have the potential fur increasmp applicalmn in 
climcal cardiology. Thi, noninvasive wchnique bar the po- 
tential lo cnhancc our underalandmg of disease procerscs 
and therapeulic agent* and pcrmil targeted therapy of indi- 
vidual palien&. 

